Adamo ML Farrar RP (2006): "Resistance training, and IGF involvement in the maintenance of muscle mass during the aging process." Ageing Res Rev 5(3):
310-331.
An J, Tzagarakis-Foster C, Scharschmidt TC, Lomri N Leitman DC (2001): "Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens." J Biol Chem 276(21): 17808-17814.
Antonio J, Wilson JD & George FW (1999): "Effects of castration and androgen treatment on androgen-receptor levels in rat skeletal muscles." J Appl Physiol 87 2016–2019.
Bartl R (2008): "[Treatment of osteoporosis according to the "European Guidance 2008".
Fracture-oriented--economical--cost-effective]." Internist (Berl) 49(9): 1126-1136.
Bhasin S Jasuja R (2009): "Selective androgen receptor modulators as function promoting therapies." Curr Opin Clin Nutr Metab Care 12(3): 232-240.
Bhasin S, Woodhouse L Storer TW (2001): "Proof of the effect of testosterone on skeletal muscle." J Endocrinol 170(1): 27-38.
Bonkhoff H, Fixemer T, Hunsicker I Remberger K (1999): "Estrogen receptor expression in prostate cancer and premalignant prostatic lesions." Am J Pathol 155(2): 641-647.
Borst SE, Conover CF, Carter CS, Gregory CM, Marzetti E, Leeuwenburgh C, Vandenborne K Wronski TJ (2007): "Anabolic effects of testosterone are preserved during inhibition of 5alpha-reductase." Am J Physiol Endocrinol Metab 293(2): E507-514.
Brossner C, Petritsch K, Fink K, Auprich M, Madersbacher S, Adlercreutz H, Rehak P Petritsch P (2004): "Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases." Urology 64(4):
707-711.
Brower KJ (2009): "Anabolic steroid abuse and dependence in clinical practice." Phys Sportsmed 37(4): 131-140.
Cardinale M, Soiza RL, Leiper JB, Gibson A Primrose WR (2008): "Hormonal responses to a single session of whole body vibration exercise in elderly individuals." Br J Sports Med 44(4):284-8
Carlson S, Peng N, Prasain JK Wyss JM (2008): "Effects of botanical dietary supplements on cardiovascular, cognitive, and metabolic function in males and
Chen Y, Zajac JD, MacLean HE (2005): "Androgen regulation of satellite cell function" J Endocrinol 186, 21-31
Clarke BL Khosla S (2009): "New selective estrogen and androgen receptor modulators."
Curr Opin Rheumatol 21(4): 374-379.
Cochrane DJ, Stannard SR, Sargeant AJ Rittweger J (2008): "The rate of muscle temperature increase during acute whole-body vibration exercise." Eur J Appl Physiol 103(4): 441-448.
Dieli-Conwright CM, Spektor TM, Rice JC Todd Schroeder E (2009): "Oestradiol and SERM treatments influence oestrogen receptor coregulator gene expression in human skeletal muscle cells." Acta Physiol (Oxf) 197(3): 187-196.
Diemer T, Hauck EW, Rohde V Weidner W (2005): "[Therapy of the "aging male"]."
Urologe A 44(10): 1173-1178.
Dixon RA (2004): "Phytoestrogens." Annu Rev Plant Biol 55: 225-261.
Drewa T Chlosta P (2010): "Testosterone supplementation and prostate cancer, controversies still exist." Acta Pol Pharm 67(5): 543-546.
Ellem SJ, Risbridger GP.(2006): "Aromatase and prostate cancer." Minerva Endocrinol 31(1):1-12.
Ellem SJ Risbridger GP (2009a): "Aromatase and regulating the estrogen:androgen ratio in the prostate gland." J Steroid Biochem Mol Biol 118(4-5):246-51
Ellem SJ Risbridger GP (2009b): "The dual, opposing roles of estrogen in the prostate."
Ann N Y Acad Sci 1155: 174-186.
Enns DL, Iqbal S Tiidus PM (2008): "Oestrogen receptors mediate oestrogen-induced increases in post-exercise rat skeletal muscle satellite cells." Acta Physiol (Oxf) 194(1): 81-93.
Evans WJ (2010) "Skeletal muscle loss: cachexia, sarcopenia, and inactivity." Am J Clin Nutr 91 1123S-1127S
Falkenstein E, Tillmann HC, Christ M, Feuring M Wehling M (2000): "Multiple actions of steroid hormones--a focus on rapid, nongenomic effects." Pharmacol Rev 52(4): 513-556.
Fallon JB, Macefield VG (2007): "Vibration sensitivity of human muscle spindles and Golgi tendon organs." Muscle Nerve 36(1):21-9.
Flieger J, Karachalios T, Khaldi L, Raptou P, Lyritis G (1998): "Mechanical stimulation in the form of vibration prevents postmenopausal bone loss in ovariectomized rats" Calcif Tissue Int 63:510-4
Frontera WR, Meredith CN, O'Reilly KP, Knuttgen HG Evans WJ (1988): "Strength conditioning in older men: skeletal muscle hypertrophy and improved function." J Appl Physiol 64(3): 1038-1044.
Gao W, Reiser PJ, Coss CC, Phelps MA, Kearbey JD, Miller DD Dalton JT (2005):
"Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats."
Endocrinology 146(11): 4887-4897.
Glenmark B, Nilsson M, Gao H, Gustafsson JA, Dahlman-Wright K Westerblad H (2004): "Difference in skeletal muscle function in males vs. females: role of estrogen receptor-beta." Am J Physiol Endocrinol Metab 287(6): E1125-1131.
Hedlund TE, Johannes WU Miller GJ (2003): "Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro." Prostate 54(1):
68-78. marker for high grade prostate cancer?" J Urol 163(3): 824-827.
Holzbeierlein JM, McLaughlin MD Thrasher JB (2004): "Complications of androgen deprivation therapy for prostate cancer." Curr Opin Urol 14(3): 177-183.
Icks A, Haastert B, Wildner M, Becker C Meyer G (2008): "Trend of hip fracture incidence in Germany 1995-2004: a population-based study." Osteoporos Int 19(8): 1139-1145.
Jankovich JP. (1972): "The effects of mechanical vibration on bone development in the rat." J Biomech 5(3):241-50.
Jones TE, Stephenson KW, King JG, Knight KR, Marshall TL Scott WB (2009):
"Sarcopenia--mechanisms and treatments." J Geriatr Phys Ther 32(2): 39-45.
Kanis JA, Oden A, Johnell O, De Laet C, Jonsson B Oglesby AK (2003): "The components of excess mortality after hip fracture." Bone 32(5): 468-473.
Kaushik MC, Misro MM, Sehgal N Nandan D (2010): "Effect of chronic oestrogen administration on androgen receptor expression in reproductive organs and pituitary of adult male rat." Andrologia 42(3): 193-205.
Kerr JF Searle J (1973): "Deletion of cells by apoptosis during castration-induced
Kim J (2008): "Protective effects of Asian dietary items on cancers - soy and ginseng."
Asian Pac J Cancer Prev 9(4): 543-548.
Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. (1998):"Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta." Endocrinology 139(10):4252-63.
Lampe JW, Karr SC, Hutchins AM Slavin JL (1998): "Urinary equol excretion with a soy challenge: influence of habitual diet." Proc Soc Exp Biol Med 217(3): 335-339.
Lang T, Streeper T, Cawthon P, Baldwin K, Taaffe DR Harris TB (2009): "Sarcopenia:
etiology, clinical consequences, intervention, and assessment." Osteoporos Int 21 (4):543-59
Lau KM, LaSpina M, Long J Ho SM (2000): "Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation." Cancer Res 60(12): 3175-3182.
Leitlinien Arbeitsmedizin (2003): "Arbeit unter Einwirkung von mechanischen Schwingungen (Arbeitsbedingte Gesundheitsschäden durch mechanische Schwingungen)"
http://www.dgaum.de/index.php/publikationen/leitlinien/leitlinienarbeitsmedizin/
86-mechanischeschwingungen
Lekas E, Johansson M, Widmark A, Bergh A Damber JE (1997): "Decrement of blood flow precedes the involution of the ventral prostate in the rat after castration."
Urol Res 25(5): 309-314.
Lemoine S, Granier P, Tiffoche C, Rannou-Bekono F, Thieulant ML Delamarche P (2003): "Estrogen receptor alpha mRNA in human skeletal muscles." Med Sci Sports Exerc 35(3): 439-443.
Lenk VS (2005): "[Diagnosis of the "aging male"--what is recommended?]." Urologe A 44(10): 1167-1172.
Li X Rahman N (2009): "Estrogens and bladder outlet obstruction." J Steroid Biochem Mol Biol 118(4-5):257-63
Lund TD, Munson DJ, Haldy ME, Setchell KD, Lephart ED Handa RJ (2004): "Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback." Biol Reprod 70(4): 1188-1195.
Maddalozzo GF, Iwaniec UT, Turner RT, Rosen CJ Widrick JJ (2008): "Whole-body vibration slows the acquisition of fat in mature female rats." Int J Obes (Lond) 32(9): 1348-1354.
Mau M, Kalbe C, Wollenhaupt K, Nürnberg G, Rehfeldt C. (2008): "IGF-I- and EGF-dependent DNA synthesis of porcine myoblasts is influenced by the dietary
Marks LS, Mazer NA, Mostaghel E, Hess DL, Dorey FJ, Epstein JI, Veltri RW, Makarov DV, Partin AW, Bostwick DG, et al. (2006): "Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial." JAMA 296(19): 2351-2361.
Marks TA, Petrow V.(1983): "Effect of the preestrogen 4-androstene-3,17-dion-19-al on the Dunning R3327 prostatic adenocarcinoma." Cancer Res 43(8):3687-90.
Marrian GF Haslewood GA (1932): "Equol, a new inactive phenol isolated from the ketohydroxyoestrin fraction of mares' urine." Biochem J 26(4): 1227-1232.
Marts SA, Padilla GM, Petrow V. (1987):" Aromatase activity in microsomes from rat ventral prostate and Dunning R3327H rat prostatic adenocarcinoma." J Steroid Biochem 26(1):25-9.
McPherson SJ, Ellem SJ, Simpson ER, Patchev V, Fritzemeier KH Risbridger GP (2007):
"Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia." Endocrinology 148(2): 566-574.
Michel G, Baulieu EE. (1976): "An approach to the anabolic action of androgens by an experimental system." Environ Qual Saf Suppl 1976(5):54-9.
Michel G, Baulieu EE. (1980): " Androgen receptor in rat skeletal muscle:
characterization and physiological variations." Endocrinology 107(6):2088-98.
Mohler ML, Bohl CE, Jones A, Coss CC, Narayanan R, He Y, Hwang DJ, Dalton JT Miller DD (2009): "Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit." J Med Chem 52(12): 3597-3617.
Morales A (2004): "Testosterone treatment for the aging man: the controversy." Curr Urol Rep 5(6): 472-477.
Morgentaler A (2009): "Rapidly shifting concepts regarding androgens and prostate cancer." ScientificWorldJournal 9: 685-690.
Muthyala RS, Ju YH, Sheng S, Williams LD, Doerge DR, Katzenellenbogen BS, Helferich WG Katzenellenbogen JA (2004): "Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta." Bioorg Med Chem 12(6): 1559-1567.
Negro-Vilar A (1999): "Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium." J Clin Endocrinol Metab 84(10): 3459-3462.
Newman AB, Kupelian V, Visser M, Simonsick EM, Goodpaster BH, Kritchevsky SB, Tylavsky FA, Rubin SM Harris TB (2006): "Strength, but not muscle mass, is
associated with mortality in the health, aging and body composition study cohort."
J Gerontol A Biol Sci Med Sci 61(1): 72-77.
Nikolic M, Bajek S, Bobinac D, Vranic TS Jerkovic R (2005): "Aging of human skeletal muscles." Coll Antropol 29(1): 67-70.
Ohlsson C Vandenput L (2009): "The role of estrogens for male bone health." Eur J Endocrinol 160(6): 883-889.
Orgaard A Jensen L (2008): "The effects of soy isoflavones on obesity." Exp Biol Med (Maywood) 233(9): 1066-1080.
Oxlund BS, Ørtoft G, Andreassen TT, Oxlund H. (2003):" Low-intensity, high-frequency vibration appears to prevent the decrease in strength of the femur and tibia associated with ovariectomy of adult rats." Bone 32(1):69-77
Page ST, Amory JK, Bowman FD, Anawalt BD, Matsumoto AM, Bremner WJ Tenover JL (2005): "Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T." J Clin Endocrinol Metab 90(3): 1502-1510.
Pelletier G (2002): "Effects of estradiol on prostate epithelial cells in the castrated rat." J Histochem Cytochem 50(11): 1517-1524.
Pettersson K, Delaunay F Gustafsson JA (2000): "Estrogen receptor beta acts as a dominant regulator of estrogen signaling." Oncogene 19(43): 4970-4978.
Preisinger E (2009): "[Physiotherapy and exercise in osteoporosis and its complications]." Z Rheumatol 68(7): 534-536, 538.
Prins GS, Birch L, Couse JF, Choi I, Katzenellenbogen B Korach KS (2001): "Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor alpha: studies with alphaERKO and betaERKO mice." Cancer Res 61(16): 6089-6097.
Rafii F, Davis C, Park M, Heinze TM Beger RD (2003): "Variations in metabolism of the soy isoflavonoid daidzein by human intestinal microfloras from different individuals." Arch Microbiol 180(1): 11-16.
Rauch F (2009): "Vibration therapy." Dev Med Child Neurol 51 Suppl 4: 166-168.
Riggs BL, Khosla S Melton LJ, 3rd (2002): "Sex steroids and the construction and conservation of the adult skeleton." Endocr Rev 23(3): 279-302.
Royuela M, de Miguel MP, Bethencourt FR, Sanchez-Chapado M, Fraile B, Arenas MI Paniagua R (2001): "Estrogen receptors alpha and beta in the normal, hyperplastic and carcinomatous human prostate." J Endocrinol 168(3): 447-454.
Russo CR, Lauretani F, Bandinelli S, Bartali B, Cavazzini C, Guralnik JM Ferrucci L (2003): "High-frequency vibration training increases muscle power in
Sadeh M (1988): "Effects of aging on skeletal muscle regeneration." J Neurol Sci 87(1):
67-74.
Sandford NL, Searle JW Kerr JF (1984): "Successive waves of apoptosis in the rat prostate after repeated withdrawal of testosterone stimulation." Pathology 16(4):
406-410.
Sandhu E, Miles JD, Dahners LE, Keller BV, Weinhold PS. (2011): " Whole body vibration increases area and stiffness of the flexor carpi ulnaris tendon in the rat."
J Biomech 44(6):1189-91.
Sarkar FH Li Y (2002): "Mechanisms of cancer chemoprevention by soy isoflavone genistein." Cancer Metastasis Rev 21(3-4): 265-280.
Schatzl G, Madersbacher S, Thurridl T, Waldmuller J, Kramer G, Haitel A Marberger M (2001): "High-grade prostate cancer is associated with low serum testosterone levels." Prostate 47(1): 52-58.
Schill WB (2001): "Fertility and sexual life of men after their forties and in older age."
Asian J Androl 3(1): 1-7.
Setchell KD Cole SJ (2006): "Method of defining equol-producer status and its frequency among vegetarians." J Nutr 136(8): 2188-2193.
Setchell KD, Brown NM, Desai P, Zimmer-Nechemias L, Wolfe BE, Brashear WT, Kirschner AS, Cassidy A Heubi JE (2001): "Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements." J Nutr 131(4 Suppl): 1362S-1375S.
Setchell KD, Brown NM Lydeking-Olsen E (2002): "The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones." J Nutr 132(12): 3577-3584.
Shabsigh A, Chang DT, Heitjan DF, Kiss A, Olsson CA, Puchner PJ Buttyan R (1998):
"Rapid reduction in blood flow to the rat ventral prostate gland after castration:
preliminary evidence that androgens influence prostate size by regulating blood flow to the prostate gland and prostatic endothelial cell survival." Prostate 36(3):
201-206.
Silbernagel S und Klinke R: Lehrbuch der Physiologie, 4. Korrig. Auflage: Georg Thieme Verlag Stuttgart 2003, S.82-105
Statistisches Bundesamt (2009): "Bevölkerungsentwicklung in Deutschland bis 2060"
http://www.destatis.de/jetspeed/portal/cms/Sites/destatis/Internet/DE/Content/Stat istiken/Bevoelkerung/VorausberechnungBevoelkerung/InteraktiveDarstellung/Int eraktiveDarstellung,templateId=renderPrint.psml
Taylor CK, Levy RM, Elliott JC Burnett BP (2009): "The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies." Nutr Rev 67(7): 398-415.
Thomas A, Bunyan K Tiidus PM "Oestrogen receptor-alpha activation augments post-exercise myoblast proliferation." Acta Physiol (Oxf) 198(1): 81-89.
Tiidus PM, Deller M Liu XL (2005): "Oestrogen influence on myogenic satellite cells following downhill running in male rats: a preliminary study." Acta Physiol Scand 184(1): 67-72.
Travis RC, Spencer EA, Allen NE, Appleby PN, Roddam AW, Overvad K, Johnsen NF, Olsen A, Kaaks R, Linseisen J, et al. (2009): "Plasma phyto-oestrogens and prostate cancer in the European Prospective Investigation into Cancer and Nutrition." Br J Cancer 100(11): 1817-1823.
Vasan S (2006): "Ageing male and testosterone: Current status and treatment guidelines"
Indian J Urol 22: 15-22
Verschueren SM, Roelants M, Delecluse C, Swinnen S, Vanderschueren D Boonen S (2004): "Effect of 6-month whole body vibration training on hip density, muscle strength, and postural control in postmenopausal women: a randomized controlled pilot study." J Bone Miner Res 19(3): 352-359.
Wang J, Eltoum IE, Carpenter M Lamartiniere CA (2009): "Genistein mechanisms and timing of prostate cancer chemoprevention in lobund-wistar rats." Asian Pac J Cancer Prev 10(1): 143-150.
Warden SJ, Hurst JA, Sanders MS, Turner CH, Burr DB Li J (2005): "Bone adaptation to a mechanical loading program significantly increases skeletal fatigue resistance."
J Bone Miner Res 20(5): 809-816.
Weidner W (2000): "[The aging man]." Urologe A 39(6): 576-577.
Weihua Z, Saji S, Makinen S, Cheng G, Jensen EV, Warner M Gustafsson JA (2000):
"Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus." Proc Natl Acad Sci U S A 97(11): 5936-5941.
White JW (1895): "I. The Results of Double Castration in Hypertrophy of the Prostate."
Ann Surg 22(1): 1-80.
Wiik A, Gustafsson T, Esbjornsson M, Johansson O, Ekman M, Sundberg CJ Jansson E (2005): "Expression of oestrogen receptor alpha and beta is higher in skeletal muscle of highly endurance-trained than of moderately active men." Acta Physiol Scand 184(2): 105-112.
Wiik A, Ekman M, Johansson O, Jansson E Esbjornsson M (2009): "Expression of both oestrogen receptor alpha and beta in human skeletal muscle tissue." Histochem Cell Biol 131(2): 181-189.
Xie L, Rubin C, Judex S. (2008): "Enhancement of the adolescent murine musculoskeletal system using low-level mechanical vibrations." J Appl Physiol 104(4):1056-62. Epub 2008 Feb 7.
Zhu YS (2005): "Molecular Basis of Steroid Action in the Prostate." Cellscience 1(4): 27-55.
Zhu YS Imperato-McGinley JL (2009): "5alpha-reductase isozymes and androgen actions in the prostate." Ann N Y Acad Sci 1155: 43-56.
Zitzmann M (2008): "[Therapy of male hypogonadism]." Internist (Berl) 49(5): 559-560, 562-554, 566-559.
Danksagung
An dieser Stelle möchte ich mich bei Herrn Prof. Dr. Wuttke für die Überlassung des interessanten Themas sowie für die großzügige Bereitstellung der Laborräume und die freundliche und unkomplizierte Betreuung während des Schreibens der Arbeit bedanken.
Meiner wissenschaftlichen Betreuerin, Frau PD Dr. med. D. Seidlová-Wuttke, möchte ich für ihr großes Interesse und die vielen praktischen Hinweise im Rahmen der labortechnischen Arbeit und des Schreibens der Arbeit danken.
Bei Frau Brüggemann-Meyer möchte ich mich ebenfalls sehr herzlich für die praktische Einführung in die Labormethoden sowie die sehr gute Zusammenarbeit und die vielen Hilfestellungen bedanken.
Lebenslauf
Ich wurde am 07.05.1980 als Kind des Versicherungskaufmanns Hans-Joachim Scharff und der medizinisch-technischen Assistentin Doris Scharff, geb. Lieb, in Freudenstadt geboren.
In Freudenstadt verbrachte ich auch meine Kindheit und besuchte von 1987 bis 1991 die dortige Hartranft-Grundschule. Nachfolgend besuchte ich das Kepler-Gymnasium und beendete meine schulische Laufbahn an der Luise-Büchner-Schule mit der allgemeinen Hochschulreife im Jahr 2000. Anschließend folgte eine Ausbildung zur biologisch-technischen Assistentin an der Jörg-Zürn-Gewerbeschule in Überlingen am Bodensee.
Diese schloss ich erfolgreich im Jahr 2002 ab.
Im Sommersemester 2002 begann ich mein Studium der Humanmedizin an der Georg-August-Universität Göttingen. Während meines Studiums famulierte ich innerhalb verschiedenster Bereiche der Medizin in Göttingen, Freudenstadt und
Ho-Chi-minh-City/Vietnam.
Das Praktische Jahr folgte 2008 mit Tertialen in Budapest (Allgemeinchirurgie), Sanderbusch (Innere Medizin) und dem Kantonsspital Sarnen in der Schweiz (Wahlfach Gynäkologie). Im Frühjahr 2009 schloss ich mein Studium der Humanmedizin mit der Zweiten Ärztlichen Prüfung erfolgreich ab.
Im Herbst 2009 begann ich meine Dissertationsarbeit unter der Leitung von Herrn Prof.
Dr. med. Wuttke, Leiter der Arbeitsgruppe Endokrinologie der Universität Göttingen.